This table presents recent patent oppositions filed by Dr. Reddy's Laboratories Limited against its competitors. It outlines key details of each case, including the patent title, filing date and the applicant. This information provides insights into the competitive landscape and highlights active disputes over patent grant within the industry.

Patent NumberTitleApplicantOpposition Date
EP2478907Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY, INC.Jan 14, 2022
EP2766040Uses For And Article Of Manufacture Including Her2 Dimerization Inhibitor PertuzumabF. HOFFMANN-LA ROCHE AGFeb 17, 2020
EP2825558Combination Therapy For The Treatment Of Ovarian CancerF. HOFFMANN-LA ROCHE AGFeb 17, 2020
EP3111954Methods Of Treating Ankylosing Spondylitis Or Psoriatic Arthritis Using Anti-Il-17 AntibodiesNOVARTIS AGJan 2, 2020
EP3300721Propylene Glycol-Containing Peptide Formulations Which Are Optimal For Production And For Use In Injection DevicesNOVO NORDISK A/SDec 5, 2019
EP2962690(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGENOct 16, 2019
EP2238172Composition Comprising Antibody That Binds To Domain Ii Of Her2 And Acidic Variants ThereofGENENTECH, INC.Nov 21, 2018
EP2704798Formulation For Anti- Alpha4Beta7 AntibodyMILLENNIUM PHARMACEUTICALS, INC.Apr 12, 2018

The following table provides an overview of the latest patents of Dr. Reddy's Laboratories Limited that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3414256Jan 19, 2022Amine Salt Of Obeticholic Acid1
EP2809773Sep 2, 2020Process Of Modulating Man5 And/Or Afucosylation Content Of Glycoprotein Composition5